NORELGESTROMIN AND ETHINLY ESTRADIOL (Norelgestromin and Ethinly Estradiol) Nursing Considerations

What is the generic name?

NORELGESTROMIN AND ETHINLY ESTRADIOL

What is the Trade Name for NORELGESTROMIN AND ETHINLY ESTRADIOL?

Norelgestromin and Ethinly Estradiol

What are the Indications for NORELGESTROMIN AND ETHINLY ESTRADIOL?

• 1 INDICATIONS AND USAGE Norelgestromin and ethinyl estradiol transdermal system is indicated for the prevention of pregnancy in women with a body mass index (BMI) < 30 kg/m 2 for whom a combined hormonal contraceptive is appropriate. Limitations of Use : Norelgestromin and ethinyl estradiol transdermal system may be less effective in preventing pregnancy in women who weigh 198 lbs (90 kg) or more. Norelgestromin and ethinyl estradiol transdermal system is contraindicated for use in women with BMI ‚â• 30 kg/m 2 [see Contraindications (4) , Warnings and Precautions (5.1) and Clinical Studies (14) ] . Norelgestromin and ethinyl estradiol transdermal system is an estrogen/progestin combination hormonal contraceptive (CHC), indicated for the prevention of pregnancy in women with a BMI < 30 kg/m 2 for whom a combined hormonal contraceptive is appropriate. ( 1 ) Limitations of Use : Norelgestromin and ethinyl estradiol transdermal system may be less effective in preventing pregnancy in women at or above 198 lbs (90 kg). ( 1 , 4 , 14 )

References: https://open.fda.gov/